1-3
2026
影响因子区间
173天
平台估算
14%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs.The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.
【译文】《组织工程与再生医学杂志》快速且严格同行评审的研究论文、评论、临床病例报告、观点和简报,涉及结合干细胞或祖细胞、生物材料和支架、生长因子和其他生物活性剂及其相应构建的治疗方法的发展相关主题。所有论文应涉及对开发新型临床方法以再生或修复组织和器官有直接或潜在影响的研究。该杂志是多学科的,涵盖生命科学和工程原理的结合,以推进医学和临床策略。该杂志专注于细胞、材料和生化/机械因素在开发恢复、维持或改善组织或器官功能生物功能替代品中的应用。该杂志发表关于任何组织或器官的研究,涵盖该领域的所有关键方面,包括新生物材料的发展支架加工;使用不同类型的细胞(主要是干细胞和祖细胞)及其在特定生物反应器中的培养;相关动物模型的研究;以及在严格监管和伦理框架下进行的人类患者临床试验。描述使用先进方法表征工程组织的手稿对杂志读者也特别感兴趣。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |